The effect of Baypamun treatment in Aujeszky's disease virus (ADV) transmission from pigs challenged with virulent ADV was evaluated. Twenty 6-week-old crossbred pigs were divided into four equal groups and subjected to either vaccination or Baypamun treatment or challenge infection with ADV. The pigs of group I were vaccinated with gEvaccine against Aujeszky's disease (Ayvac, Pliva, Zagreb, Croatia), the pigs of group II were treated by Baypamun as a non-specific immunostimulating agent, those of group III were inoculated with a virulent strain of Aujeszky's disease virus strain NIA-3, and group IV was used as control. After challenge infection of pigs of group III, all other groups were housed together. The amount of total antibodies and gE antibodies to Aujeszky's disease virus in sera of tested piglets was determined by immunoenzyme test. Isolation of PBL and lymphocyte stimulation test also was carried out. Our results indicate that pigs of groups I and II were better protected from, or less affected by, contact infection, respectively. Significantly higher mortality was detected in pigs of group III than in any other group. In this group, the most extensive pathomorphologic changes were also found. However, they were similar in group II and group IV. The former group of pigs had a lower incidence of diarrhoea (0/5 : 2/5) and increased reactivity of T and B cells compared to controls (group IV). Although Baypamun did not affect specific antibody production, the obtained results are encouraging, with regard to the non-specific immunostimulatory effect of BPM in pigs exposed to contact ADV infection.